148 related articles for article (PubMed ID: 36810620)
1. Aldosterone breakthrough from a pharmacological perspective.
Alfie J
Hypertens Res; 2023 May; 46(5):1350. PubMed ID: 36810620
[No Abstract] [Full Text] [Related]
2. Aldosterone breakthrough from a pharmacological perspective.
Mogi M
Hypertens Res; 2022 Jun; 45(6):967-975. PubMed ID: 35422512
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?
Rossi GP
Curr Hypertens Rep; 2006 Jun; 8(3):262-8. PubMed ID: 17147926
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
[TBL] [Abstract][Full Text] [Related]
5. [Blockade of renin-angiotensin system and aldosterone breakthrough].
Naruse M; Nagata D; Seta K; Tanabe A
Nihon Rinsho; 2005 Mar; 63 Suppl 3():201-5. PubMed ID: 15813068
[No Abstract] [Full Text] [Related]
6. Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist.
Sato A; Fukuda S
Hypertens Res; 2013 Oct; 36(10):879-84. PubMed ID: 23864056
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy.
Bomback AS; Rekhtman Y; Klemmer PJ; Canetta PA; Radhakrishnan J; Appel GB
J Am Soc Hypertens; 2012; 6(5):338-45. PubMed ID: 22995802
[TBL] [Abstract][Full Text] [Related]
8. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
9. First orally active DRI Aliskiren--a new prospect in management of hypertension and beyond.
Sawhney JP
Indian Heart J; 2010; 62(1):49-56. PubMed ID: 21180035
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
11. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
Nishiyama A; Kim-Mitsuyama S
J Pharmacol Sci; 2010; 113(4):289-91. PubMed ID: 20675960
[TBL] [Abstract][Full Text] [Related]
12. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone synthase inhibition in hypertension.
Andersen K
Curr Hypertens Rep; 2013 Oct; 15(5):484-8. PubMed ID: 23917810
[TBL] [Abstract][Full Text] [Related]
14. New approaches to blockade of the renin-angiotensin-aldosterone system: mineralocorticoid-receptor blockers exert antihypertensive and renoprotective effects independently of the renin-angiotensin system.
Nishiyama A; Hasegawa K; Diah S; Hitomi H
J Pharmacol Sci; 2010; 113(4):310-4. PubMed ID: 20675957
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease.
Ames MK; Vaden SL; Atkins CE; Palerme JS; Langston CE; Grauer GF; Shropshire S; Bove C; Webb T
J Vet Intern Med; 2022 Nov; 36(6):2088-2097. PubMed ID: 36350258
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
Volpe M; Danser AH; Menard J; Waeber B; Mueller DN; Maggioni AP; Ruilope LM
J Hypertens; 2012 Apr; 30(4):647-54. PubMed ID: 22278139
[TBL] [Abstract][Full Text] [Related]
17. The state of the renin-angiotensin-aldosterone system in various clinical forms of hypertension in aging.
Chebotarev DF; Korkushko OV; Asinova MI; Ershova GS
Arch Gerontol Geriatr; 1985 Apr; 4(1):21-8. PubMed ID: 3890783
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for a role of the renin-angiotensin system in regulation of aldosterone secretion.
MULROW PJ; GANONG WF; BORYCZKA A
Proc Soc Exp Biol Med; 1963 Jan; 112():7-10. PubMed ID: 13936572
[No Abstract] [Full Text] [Related]
19. Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockade.
Davis JO; Freeman RH
Am J Cardiol; 1982 Apr; 49(6):1385-9. PubMed ID: 6280472
[TBL] [Abstract][Full Text] [Related]
20. Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
Burrello J; Buffolo F; Domenig O; Tetti M; Pecori A; Monticone S; Poglitsch M; Mulatero P
Hypertension; 2020 Jan; 75(1):163-172. PubMed ID: 31760886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
